At the heart of CHF’s policy agenda is patient-centred care. Our responses to the TGA’s consultation has been formed with a patient-centred approach in mind.
CHF notes that this consultation’s scope is limited to the regulatory guidance in line with existing regulatory requirements, and not changes to those regulatory requirements. However, as other consultations are currently open to change regulations for Software as a Medical Device (SaMD) it would be remiss for CHF to not include some forward-looking advice on out of scope but related matters.
Publication type:
Publish date:
Tuesday, March 5, 2019